Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

NCT03614923 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

105

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Rhinosinusitis

Interventions

BIOLOGICAL: Etokimab
BIOLOGICAL: Placebo
DRUG: Mometasone Furoate Nasal Spray

Sponsor

AnaptysBio, Inc.